Tina Birgitte Hansen|Jes S. Lindholt|Rikke Søgaard
Role of Experience With Preventive Medication and Personal Risk Attitude in Non-Attendance at Triple Vascular Screening
Zealand University Hospital|Odense University Hospital|Regionshospitalet Viborg|Aarhus University
backgroundnonattendance vascular screening potentially restricts overall benefit screening population level may result rational judgment part invitees might consider risk relevant aim study investigate role current use preventive medication personal risk attitude potential factors explaining nonattendance triple vascular screeningmethodsthis case control study across 25078 men offered screening intervention abdominal aortic aneurysm peripheral artery disease hypertension viborg vascular viva screening trial data sociodemographic socioeconomic characteristics diagnoses use preventive medication extracted national registries proxy personal risk attitude constructed logistic regression used estimate odds ratios 95 confidence intervalsresultsuse statins 078 95 ci 071085 antihypertensives 126 95 ci 113141 antithrombotics 113 95 ci 104123 associated nonattendance regards personal risk attitude statistically significant association found users preventive medication recent diagnosis cardiovascular disease nonattendance 082 95 ci 072094 role traditional factors explaining nonattendance vascular screening low socioeconomic status comorbidity confirmedconclusionnonattendance triple vascular screening influenced use preventive medications traditional explanatory factors nonattendance vascular screening including existing cvd comorbidity attendance rates might benefit rethinking risk communication alongside screening invitations according varying invitee profiles clinical risk scenarios providing interventions targeted individuals lower levels health literacy nonattendance vascular screening potentially restricts overall benefit screening population level may result rational judgment part invitees might consider risk relevant aim study investigate role current use preventive medication personal risk attitude potential factors explaining nonattendance triple vascular screening case control study across 25078 men offered screening intervention abdominal aortic aneurysm peripheral artery disease hypertension viborg vascular viva screening trial data sociodemographic socioeconomic characteristics diagnoses use preventive medication extracted national registries proxy personal risk attitude constructed logistic regression used estimate odds ratios 95 confidence intervals use statins 078 95 ci 071085 antihypertensives 126 95 ci 113141 antithrombotics 113 95 ci 104123 associated nonattendance regards personal risk attitude statistically significant association found users preventive medication recent diagnosis cardiovascular disease nonattendance 082 95 ci 072094 role traditional factors explaining nonattendance vascular screening low socioeconomic status comorbidity confirmed nonattendance triple vascular screening influenced use preventive medications traditional explanatory factors nonattendance vascular screening including existing cvd comorbidity attendance rates might benefit rethinking risk communication alongside screening invitations according varying invitee profiles clinical risk scenarios providing interventions targeted individuals lower levels health literacy